The trajectory of Sildenafil presents a complex case for investors in the medicinal sector. While initially a phenomenal success, generating huge profits, the patent end and the subsequent entry of generic competitors https://onlinepharmacy963033.blog-ezine.com/42353330/viagra-and-big-pharma-a-risky-investment